On June 3, 2025, European Commission announced to add N,N-dimethylacetamide (DMAC) and 1-ethylpyrrolidin-2-one (NEP) to the Restriction List under REACH (Annex XVII to Regulation (EC) No 1907/2006).
Original regulatory document


Request a Demo